PYODERMA GANGRENOSUM
Clinical trials for PYODERMA GANGRENOSUM explained in plain language.
Never miss a new study
Get alerted when new PYODERMA GANGRENOSUM trials appear
Sign up with your email to follow new studies for PYODERMA GANGRENOSUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot aims to heal painful skin ulcers
Disease control Not yet recruitingThis study tests a new medicine called SHR-1139 for people with pyoderma gangrenosum, a rare skin condition that causes painful ulcers. The goal is to see if the drug can fully close the ulcers and keep them closed. About 20 adults will take part in this early-stage trial.
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 26, 2026 07:13 UTC
-
New shot aims to heal stubborn skin ulcers in rare disease
Disease control Not yet recruitingThis early study tests an injection called SHR-1139 in 10 adults with ulcerative pyoderma gangrenosum, a rare condition causing painful skin ulcers. The main goal is to see if the treatment can fully close the target ulcer by 12 weeks. Researchers will also check for side effects…
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE2 • Sponsor: Shandong First Medical University • Aim: Disease control
Last updated May 26, 2026 07:09 UTC
-
Oxygen chamber trial targets dozens of diseases
Disease control Not yet recruitingThis study will test if hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) helps people with over 30 different conditions, including long COVID, Crohn's disease, frostbite, and multiple sclerosis. About 100 participants will receive the treatment and repor…
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE4 • Sponsor: Jay C. Buckey Jr. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC